Related references
Note: Only part of the references are listed.No shortcuts to SARS-CoV-2 antivirals
Aled Edwards et al.
SCIENCE (2021)
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
Tia A. Tummino et al.
SCIENCE (2021)
NDRG1 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase
Lianghui Dong et al.
PLOS PATHOGENS (2021)
Baloxavir: A Novel Antiviral Agent in the Treatment of Influenza
George M. Abraham et al.
CLINICAL INFECTIOUS DISEASES (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Modeling mitigation of influenza epidemics by baloxavir
Zhanwei Du et al.
NATURE COMMUNICATIONS (2020)
High-risk Groups for Influenza Complications
Timothy M. Uyeki
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5
Gregory Mohl et al.
ANTIVIRAL RESEARCH (2019)
Structures of influenza A virus RNA polymerase offer insight into viral genome replication
Haitian Fan et al.
NATURE (2019)
Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors
Jian Xiong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
Larisa V. Gubareva et al.
EUROSURVEILLANCE (2019)
Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics
Zhongxia Zhou et al.
DRUG DISCOVERY TODAY (2018)
65 years of influenza surveillance by a World Health Organization-coordinated global network
Thedi Ziegler et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
Sangita Venkataraman et al.
VIRUSES-BASEL (2018)
Reassessing the Global Mortality Burden of the 1918 Influenza Pandemic
Peter Spreeuwenberg et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors
Yongshi Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a PB2 Inhibitor
Teng Liu et al.
MOLECULAR PHARMACEUTICS (2018)
Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance
Julianna Han et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer
Xingsen Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
Emi Takashita et al.
FRONTIERS IN MICROBIOLOGY (2018)
Demonstration of AutoDock as an Educational Tool for Drug Discovery
Travis R. Helgren et al.
JOURNAL OF CHEMICAL EDUCATION (2017)
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives
Han Ju et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2017)
Furan-carboxamide derivatives as novel inhibitors of lethal H5N1 influenza A viruses
Yongshi Yu et al.
RSC ADVANCES (2017)
Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir
Emi Takashita et al.
ANTIVIRAL RESEARCH (2016)
Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling
Iuni M. L. Trist et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti -influenza Therapeutics
Serena Massari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fragment-Based Identification of Influenza Endonuclease Inhibitors
Cy V. Credille et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The pandemic potential of avian influenza A(H7N9) virus: a review
W. D. Tanner et al.
EPIDEMIOLOGY AND INFECTION (2015)
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits
Serena Massari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis of N-benzyl-N-phenylthiophene-2-carboxamide analogues as a novel class of enterovirus 71 inhibitors
Jiawei Pan et al.
RSC ADVANCES (2015)
New small-molecule drug design strategies for fighting resistant influenza A
Zuyuan Shen et al.
ACTA PHARMACEUTICA SINICA B (2015)
Adamantane-Resistant Influenza A Viruses in the World (1902-2013): Frequency and Distribution of M2 Gene Mutations
Guoying Dong et al.
PLOS ONE (2015)
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Takashi Nagata et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2015)
Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Xin Han et al.
RSC ADVANCES (2015)
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds
Susan Lepri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Phenyl Substituted 4-Hydroxypyridazin-3(2H)-ones and 5-Hydroxypyrimidin-4(3H)-ones: Inhibitors of Influenza A Endonuclease
Hye Yeon Sagong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
Michael P. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structural insight into cap-snatching and RNA synthesis by influenza polymerase
Stefan Reich et al.
NATURE (2014)
Synthesis and SARs of indole-based alpha-amino acids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Xin Han et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Influenza virus resistance to neuraminidase inhibitors
Melanie Samson et al.
ANTIVIRAL RESEARCH (2013)
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly
Serena Massari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Identification of BPR3P0128 as an Inhibitor of Cap-Snatching Activities of Influenza Virus
John T. -A. Hsu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discovery of Spiro-Piperidine Inhibitors and Their Modulation of the Dynamics of the M2 Proton Channel from Influenza A Virus
Jun Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication
Makoto Ozawa et al.
JOURNAL OF VIROLOGY (2007)
Antiviral agents active against influenza A viruses
Erik De Clercq
NATURE REVIEWS DRUG DISCOVERY (2006)
Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication
A Lutz et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
The metabolism of quinone-containing alkylating agents: Free radical production and measurement
PL Gutierrez
FRONTIERS IN BIOSCIENCE-LANDMARK (2000)